First Circuit· 2/20/2015
Marcus v. Forest Pharmaceuticals, Inc.
Citations
- 779 F.3d 34
- 2015 WL 727970
How courts have described this case
Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.
- finding that plaintiff must allege a label deficiency that defendant \could have corrected using the CBE regulation.\
- “Our review of the Supreme Court opinions discussed above makes clear that a necessary step in defeating Forest’s preemption defense is to establish that the complaint alleges a labeling deficiency that Forest could have corrected using the CBE regulation.”
Source: CourtListener parenthetical corpus (CC0).
Judges: Lynch, Selya, Kayatta
Read full opinion on CourtListenerCited by
23 cases in this archive cite this case; the 20 most cited are listed.
- Gibbons v. Bristol-Myers Squibb Co.Second Circuit· 2019-03-26· cited 262×
- Gustavsen v. Alcon Laboratories, Inc.First Circuit· 2018-08-27· cited 61×
- Kaufman v. CVS Caremark Corp.First Circuit· 2016-09-06· cited 40×
- Painters & Allied Trades Dist. Council 82 Health Care Fund v. Forest Pharm., Inc. (In Re Celexa & Lexapro Mktg. & Sales Practices Litig.)First Circuit· 2019-01-30· cited 40×
- Dolin v. GlaxoSmithKline LLCSeventh Circuit· 2018-08-22· cited 33×
- Franklin California Tax-Free v. Commonwealth of Puerto RicoFirst Circuit· 2015-07-06· cited 29×
- Brazil v. Janssen Research & Development LLCN.D. Georgia· 2016-07-11· cited 16×
- Utts v. Bristol-Myers Squibb Co.S.D. New York· 2016-12-23· cited 14×
- Aubee v. Selene Finance LPFirst Circuit· 2022-12-21· cited 12×
- In Re: Zofran (Ondansetron) Products Liability Lit v.First Circuit· 2023-01-09· cited 8×
- In re Tylenol (Acetaminophen) Marketing, Sales Practices & Products Liability LitigationE.D. Pennsylvania· 2015-11-13· cited 5×
- Seufert v. Merck Sharp & Dohme Corp.S.D. California· 2016-05-11· cited 5×
- Christison v. Biogen Idec Inc.D. Utah· 2016-08-05· cited 5×
- Portland Pipe Line Corp. v. City of S. PortlandD. Maine· 2017-12-29· cited 5×
- Ouellette v. MillsD. Maine· 2015-02-23· cited 3×
- In re Lipitor (Atorvastatin Calcium) Marketing, Sales Practices & Products Liability LitigationD. South Carolina· 2016-05-06· cited 3×
- Painters & Allied Trades Dist. Council 82 Health Care Fund v. Forest Labs., Inc. (In re Celexa & Lexapro Mktg. & Sales Practices Litig.)District of Columbia· 2018-01-26· cited 2×
- Painters & Allied Trades District Council 82 Health Care Fund v. Forest Laboratories, Inc.D. Massachusetts· 2016-06-02· cited 2×
- In re Zofran (Ondansetron) Prods. Liab. Litig.District of Columbia· 2019-02-05· cited 1×
- Wendy B. Dolin v. GlaxoSmithKline LLCSeventh Circuit· 2018-08-22
Cites
8 cases in this archive are cited by this case.
- English v. General Electric Co.Supreme Court· 1990-06-04· cited 1,390×
- Cel-Tech Communications, Inc. v. Los Angeles Cellular Telephone Co.California Supreme Court· 1999-04-08· cited 1,311×
- Wyeth v. LevineSupreme Court· 2009-03-04· cited 1,294×
- Freightliner Corp. v. MyrickSupreme Court· 1995-04-18· cited 675×
- PLIVA, Inc. v. MensingSupreme Court· 2011-06-23· cited 428×
- Mut. Pharm. Co. v. BartlettSupreme Court· 2013-06-24· cited 252×
- Cooper v. Charter Communications Entertainments I, LLCFirst Circuit· 2014-07-23· cited 36×
- Debnam v. FedEx Home DeliveryFirst Circuit· 2014-09-08· cited 19×
Sourced from CourtListener / Free Law Project (CC0).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.